Phosphoproteomics and lung cancer research

Elena López1, William C S Cho

  • 1Hospital Universitario Niño Jesús, Department of Oncohematology of Children, Madrid 28009, Spain. williamcscho@gmail.com.

Summary

Genetic abnormalities drive lung cancer. Phosphoproteomics helps identify diagnostic and therapeutic biomarkers by analyzing protein modifications for personalized lung cancer treatment.